BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee SY. [New guidelines for Helicobacter pylori treatment: comparisons between Korea and Japan]. Korean J Gastroenterol 2014;63:151-7. [PMID: 24651588 DOI: 10.4166/kjg.2014.63.3.151] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Huh CW, Kim B. Diagnosis of Helicobacter pylori Infection. Korean J Gastroenterol 2018;72:229. [DOI: 10.4166/kjg.2018.72.5.229] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kim JH. Recent Update on Third-line Helicobacter pylori Eradication. Korean J Helicobacter Up Gastrointest Res 2015;15:89. [DOI: 10.7704/kjhugr.2015.15.2.89] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
3 Yoon H. Atrophic Gastritis and Intestinal Metaplasia. In: Kim N, editor. Helicobacter pylori. Singapore: Springer; 2016. pp. 515-20. [DOI: 10.1007/978-981-287-706-2_52] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
4 Choi JM, Kim SG. Diagnosis and Treatment of <i>Helicobacter Pylori</i> Infection: Korean and Overseas Guidelines. Korean J Med 2015;89:157-68. [DOI: 10.3904/kjm.2015.89.2.157] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
5 Kim JH, Lee S, Kwon HG, Lee SP, Kim JH, Sung I, Park HS, Shim CS. Serological Changes after Equivocal Helicobacter pylori -serology Test Findings Dependent on Gastric Secreting Ability. Korean J Gastroenterol 2017;70:181. [DOI: 10.4166/kjg.2017.70.4.181] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
6 Seo JH, Park JS, Rhee KH, Youn HS. Diagnosis of Helicobacter pylori Infection in Children and Adolescents in Korea. Pediatr Gastroenterol Hepatol Nutr 2018;21:219-33. [PMID: 30345235 DOI: 10.5223/pghn.2018.21.4.219] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Abadi ATB, Ierardi E. Vonoprazan and Helicobacter pylori Treatment: A Lesson From Japan or a Limited Geographic Phenomenon? Front Pharmacol. 2019;10:316. [PMID: 31024299 DOI: 10.3389/fphar.2019.00316] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
8 Chung GE, Chung SJ, Yang JI, Jin EH, Park MJ, Kim SG, Kim JS. Development of Metachronous Tumors after Endoscopic Resection for Gastric Neoplasm according to the Baseline Tumor Grade at a Health Checkup Center. Korean J Gastroenterol 2017;70:223. [DOI: 10.4166/kjg.2017.70.5.223] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
9 Lim SH, Kim N, Kim SE, Baik GH, Lee JY, Park KS, Shin JE, Song HJ, Myung D, Choi SC, Kim HJ. A Comparison of Accuracy between IMMULITE2000® and GENEDIA® for Helicobacter pylori Infection. Korean J Helicobacter Up Gastrointest Res 2020;20:54-62. [DOI: 10.7704/kjhugr.2019.0014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Choi JH, Yang YJ, Bang CS, Lee JJ, Baik GH. Current Status of the Third-Line Helicobacter pylori Eradication. Gastroenterol Res Pract 2018;2018:6523653. [PMID: 29853863 DOI: 10.1155/2018/6523653] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
11 Chang JY, Shim KN, Tae CH, Lee KE, Lee J, Lee KH, Moon CM, Kim SE, Jung HK, Jung SA. Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication. BMC Gastroenterol 2017;17:16. [PMID: 28109257 DOI: 10.1186/s12876-017-0579-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]